Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of doxorubicin and docetaxel in treating women who have stage III breast cancer.

Key facts

Study ID

NCT00005800

Run by

H. Lee Moffitt Cancer Center and Research Institute

People needed

45

Starts

1999-04-01

Expected to finish

2012-05-01

Last updated by the study team

2012-09-25

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

Where it is running

• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.